-
-
-
-
-
-
-
CG Oncology (CGON) PT Raised to $77 at Truist Securities
-
-
-
-
-
-
-
Truist Securities Reiterates Buy Rating on CG Oncology (CGON) following JNJ erda-i data presentation
-
-
-
-
-
-
-
Wedbush Starts CG Oncology (CGON) at Outperform
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on CG Oncology (CGON)
-
-
-
-
-
-
-
CG Oncology wins court case, avoids 5% royalty to ANI Pharmaceuticals
-
-
-
-
-
-
-
CG Oncology (CGON) Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec
-
-
-
-
-
-
-
CG Oncology (CGON) Announces Proposed 7.3M Share Offering
-
447,920 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

